Geneoscopy, Inc
St. Louis, US · Founded 2019 · Delaware corporation · 79 employees on LinkedIn · 5 known investors
Find your way into Geneoscopy, Inc
Sign up to see every warm intro you have to Geneoscopy, Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Geneoscopy, Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
Founders & leadership
Geneoscopy, Inc was founded in 2019 by Andrew Barnell and Erica Barnell.


Investors · 5
How we know: BioGenerator Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: iSelect Fund's portfolio page · Not right? Tell us
How we know: Missouri Technology Corporation's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$163.4M disclosed across 3 of 4 rounds · 2019–2025
▶$50.5MraisedNov 2021 · 85 investors · Other Health CareRule 506(b)
- JAMES MERSELISDirector
- ERICA BARNELLExecutive Officer, Director
- NAJEEB THOMASDirector
- ANDREW BARNELLExecutive Officer, Director
- MARK ZORENSKYDirector
- DREW DENNISONDirector
- BOBBY W. SANDAGE, JR.Director
- Offering amount
- $50.5M
- Amount sold
- $50.5M
- Minimum investment
- $1
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$7.9MraisedSep 2019 · 57 investors · Other Health CareRule 506(b)
- ANDREW BARNELLExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Companies working in the same space as Geneoscopy, Inc.
In the news
Frequently asked questions
- What does Geneoscopy, Inc do?
- Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
- Who founded Geneoscopy, Inc?
- Geneoscopy, Inc was founded by Andrew Barnell, Erica Barnell in 2019.
- Who are Geneoscopy, Inc's investors?
- Geneoscopy, Inc's investors include BioGenerator Ventures, Dorm Room, iSelect Fund, Missouri Technology Corporation, Cultivation Capital.
- How much funding has Geneoscopy, Inc raised?
- Geneoscopy, Inc has disclosed $163.4M raised across 3 of its 4 known rounds.
- Where is Geneoscopy, Inc headquartered?
- Geneoscopy, Inc is headquartered in St. Louis, US.







